Kairos Pharma Ltd 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Kairos Pharma Ltd 's ROA in the second quarter of 2026?
Kairos Pharma Ltd recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -85.86%.

However, within the Healthcare sector 719 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4205, from total ROA ranking in the first quarter of 2026 at 4838.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	0.33 %	-27.63 %	13.38 %	61.19 %	162.1 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-6	-6	-5	-3	-3
Return On Assets (TTM)	-85.86 %	-86.43 %	-74.58 %	-42.68 %	-42.3 %
KAPA's Total Ranking	# 4205	# 4838	# 3936	# 3984	#
Total Assets (TTM) in million	7	6	7	8	7
Seq. Total Assets Change	16.56 %	-12.17 %	-18.92 %	20.88 %	-15.93 %
Seq. Net Income Change	-	-	-	-	-

KAPA's 5 Years Annual ROA >> Back to KAPA Management Effectiveness >> Compare KAPA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 331
Sector	# 720
Overall	# 4190

Return On Assets Statistics
High	Average	Low
-42.3 %	-67.92 %	-93.61 %
(Jun 30 2025)		(Jun 30 2026)

Financial Statements
Kairos Pharma Ltd 's Assets	$ 7 million	KAPA's Balance sheet
Kairos Pharma Ltd 's Income	$ -1 million	Quarterly KAPA's Income Statement
KAPA's Income by Division		See KAPA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	13.38 %	-	-	-	-
Total Assets in million	7	6	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-5	-3	0	0	0
Annual Return On Assets	-83.29 %	-45.13 %	-	-	-

KAPA's 5 Years Annual ROA >> Back to KAPA Management Effectiveness >> Compare KAPA ROA to its Competitors

More Return On Assets Ratios
KAPA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
KAPA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for KAPA's Competitors
Subscribers only: Roa for Kairos Pharma Ltd 's Suppliers
Subscribers only: Return On Assets for KAPA's Customers

You may also want to know
KAPA's Roi	KAPA's Inventory Turnover Ratio	KAPA's Growth Rates	KAPA's Dividend Comparisons
	KAPA's Profitability Ratios	KAPA's Asset Turnover Ratio	KAPA's Dividend Growth
KAPA's Roe	KAPA's Valuation Ratios	KAPA's Financial Strength Ratios	KAPA's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-03T23:52:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.